StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by Thehuntsmanon Nov 19, 2017 9:19am

210 Views

Post# 26991626

I have been following this for about 6 months

There was so much bashing and bs on this board I never had the inclination to join stock house. I managed to secure 200k at .09 over the last month or so. I listened to the q2 call and I am confident things will pick up well in the next few months/years. It would be great if genenews could pen a $1.8 billion deal with some huge american health group. I don't have much to offer but I will be reading all I can about this company and might be able to join in the conversation later on. If it picks up, I will buy more. Cheers.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?